MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/08923973.2017.1407941

Медицинская библиотека · Immunopharmacology and immunotoxicology · 2017

The role of LPD-nanoparticles containing recombinant major surface glycoprotein of Leishmania (rgp63) in protection against leishmaniasis in murine model.

Firouzmand Hengameh, Sahranavard Mehrnosh, Badiee Ali, Khamesipour Ali, Alavizadeh Seyedeh Hoda, Samiei Afshin, Soroush Dina, Tavassoti Kheiri Masoumeh, Mahboudi Fereidoun, Jaafari Mahmoud Reza

СтатьяПеревод пока не подготовлен

Аннотация

CONTEXT: Leishmaniasis is a major public health problem. Despite numerous attempts, yet there is no effective vaccine against human leishmaniasis, mainly due to a lack of an effective vaccine delivery system as well as adjuvant.

OBJECTIVE(S): The aim of this study was to evaluate the ability of recombinant glycoprotein 63 (rgp63) as a model of Leishmania antigen, entrapped in liposome-polycation-DNA (LPD) complexes nanoparticles in inducing cell mediated immune (CMI) response and protecting against L. major in BALB/c mice.

MATERIALS AND

METHODS

To this end, the abundant leishmania promastigote cell surface glycoprotein, gp63, was entrapped in nano-sized LPD (CpG) particles, (LPD (CpG)-rgp63), and BALB/c mice were immunized three times with either (LPD (CpG)-rgp63) or rgp63-CpG DNA or LPD (CpG) or free rgp63 and dextrose 5%. Various parameters including footpad thickness, splenic load of L. major parasites, rgp63-binding IgGs and also cytokine levels of rgp63-reactive T lymphocytes were then compared among different vaccinated animals.

RESULTS

The lowest number of parasites in spleen, the higher levels of IgG2a after challenge infection, the minimal footpad swelling and high level of IFN-γ secretion, all indicated that adjuvants and antigen-delivery systems are essential in modifying immune responses; as mice received LPD (CpG)-rgp63 induced immune response stronger than the other groups.

CONCLUSIONS

This study demonstrates that LPD nanoparticle is a promising and adaptable delivery system which could be modified towards specific vaccine targets to induce a more potent immune response in combination with rgp63.

Для цитирования: Firouzmand Hengameh, Sahranavard Mehrnosh, Badiee Ali, Khamesipour Ali, Alavizadeh Seyedeh Hoda, Samiei Afshin, Soroush Dina, Tavassoti Kheiri Masoumeh, Mahboudi Fereidoun, Jaafari Mahmoud Reza. The role of LPD-nanoparticles containing recombinant major surface glycoprotein of Leishmania (rgp63) in protection against leishmaniasis in murine model.. Immunopharmacology and immunotoxicology. 2017. DOI: 10.1080/08923973.2017.1407941.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.